AI can augment oncology nursing through symptom triage support, trial matching, care plan personalization, pharmacogenomics ...

Learn the risk factors, symptoms and screening options tied to colorectal cancer as cases continue rising among younger ...

Ongoing annual imaging of the remaining breast, plus peer navigation and patient self-advocacy, are framed as practical ...

A moving journey through breast cancer, discovering that vulnerability is courage and a diagnosis doesn't have to define your spirit or faith. A breast cancer survivor shares how faith and community ...

Some patients treated with immunotherapy may develop lifelong endocrine conditions requiring ongoing hormone replacement, ...

Melanoma patients preparing for inpatient TIL therapy learn what to pack, how chemo feels, and how IL‑2 side effects are managed. Close monitoring during interleukin-2 (IL-2) therapy is essential for ...

Researchers at Moffitt Cancer Center are studying a new topical therapy called DYV800 that may help the immune system fight ...

New research suggests biologic aging and neighborhood-related stress may affect how aerobic exercise influences cognition after breast cancer treatment.

FDA accelerated approval covers relapsed/refractory MCL after ≥2 lines including a BTK inhibitor, positioning sonrotoclax as ...

New research shows that lymphoma survivors often face long-term peripheral neuropathy, which may be more severe than what ...

Neoadjuvant Enhertu→THP improved pCR to 67.3% vs 56.3% with AC→THP in stage II–III high-risk HER2-positive disease (DESTINY-Breast11). Adjuvant Enhertu achieved 3-year IDFS 92.4% vs 83.7% with T-DM1 ...